These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30369997)

  • 41. Validation of the revised Addenbrooke's Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Kishimoto Y; Takeda N; Oshima E; Hirayama K; Yokota O; Uchitomi Y
    Int Psychogeriatr; 2012 Jan; 24(1):28-37. PubMed ID: 21843399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of Addenbrooke's cognitive examination (ACE) in a Persian-speaking population.
    Pouretemad HR; Khatibi A; Ganjavi A; Shams J; Zarei M
    Dement Geriatr Cogn Disord; 2009; 28(4):343-7. PubMed ID: 19864908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Argentinian/Chilean validation of the Spanish-language version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Bruno D; Slachevsky A; Fiorentino N; Rueda DS; Bruno G; Tagle AR; Olavarria L; Flores P; Lillo P; Roca M; Torralva T
    Neurologia (Engl Ed); 2020 Mar; 35(2):82-88. PubMed ID: 28865943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Comparison of the Greek ACE-III, M-ACE, ACE-R, MMSE, and ECAS in the Assessment and Identification of Alzheimer's Disease.
    Kourtesis P; Margioti E; Demenega C; Christidi F; Abrahams S
    J Int Neuropsychol Soc; 2020 Sep; 26(8):825-834. PubMed ID: 32312343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of Addenbrooke's cognitive examination for detecting early dementia in a Japanese population.
    Yoshida H; Terada S; Honda H; Ata T; Takeda N; Kishimoto Y; Oshima E; Ishihara T; Kuroda S
    Psychiatry Res; 2011 Jan; 185(1-2):211-4. PubMed ID: 20537725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Psychometric properties and diagnostic usefulness of the Addenbrooke's Cognitive Examination-Revised in a Chilean elderly sample].
    Muñoz-Neira C; Henríquez Ch F; Ihnen J J; Sánchez C M; Flores M P; Slachevsky Ch A
    Rev Med Chil; 2012 Aug; 140(8):1006-13. PubMed ID: 23282773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Usefulness of the Polish versions of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination as screening instruments for the detection of mild neurocognitive disorder.
    Sokołowska N; Sokołowski R; Oleksy E; Kasperska P; Klimkiewicz-Wszelaki K; Polak-Szabela A; Podhorecka M; Kędziora-Kornatowska K
    Neurol Neurochir Pol; 2020; 54(5):440-448. PubMed ID: 32808669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
    Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
    HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia.
    Peixoto B; Machado M; Rocha P; Macedo C; Machado A; Baeta É; Gonçalves G; Pimentel P; Lopes E; Monteiro L
    Adv Clin Exp Med; 2018 Jun; 27(6):781-786. PubMed ID: 29790690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free-Cog: Pragmatic Test Accuracy Study and Comparison with Mini-Addenbrooke's Cognitive Examination.
    Larner AJ
    Dement Geriatr Cogn Disord; 2019; 47(4-6):254-263. PubMed ID: 31315124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the Danish Addenbrooke's Cognitive Examination as a screening test in a memory clinic.
    Stokholm J; Vogel A; Johannsen P; Waldemar G
    Dement Geriatr Cogn Disord; 2009; 27(4):361-5. PubMed ID: 19299896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of three cognitive screening tools in a sample of older New Zealanders.
    Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
    Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Utility of the Mini-Addenbrooke's Cognitive Examination as a Screen for Cognitive Impairment in Elderly Patients with Chronic Kidney Disease and Diabetes.
    Hobson P; Rohoma KH; Wong SP; Kumwenda MJ
    Dement Geriatr Cogn Dis Extra; 2016; 6(3):541-548. PubMed ID: 28101100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the Sinhala Version of the Addenbrooke's Cognitive Examination-Revised for the Detection of Dementia in Sri Lanka: Comparison with the Mini-Mental Status Examination and the Montreal Cognitive Assessment.
    Suriyakumara V; Srikanth S; Wijeyekoon R; Gunasekara H; Muthukuda C; Rajapaksha D; Weerasekara R; Gonawala L; Wijekoon N; de Silva KRD
    Dement Geriatr Cogn Disord; 2019; 47(4-6):198-208. PubMed ID: 31311022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia.
    Kan KC; Subramaniam P; Shahrizaila N; Kamaruzzaman SB; Razali R; Ghazali SE
    Dement Geriatr Cogn Dis Extra; 2019; 9(1):66-76. PubMed ID: 31043965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dementia Diagnosis in Seven Languages: The Addenbrooke's Cognitive Examination-III in India.
    Mekala S; Paplikar A; Mioshi E; Kaul S; Divyaraj G; Coughlan G; Ellajosyula R; Jala S; Menon R; Narayanan J; Narayan S; Aghoram R; Nehra A; Rajan A; Sabnis P; Singh SK; Tripathi M; Verma M; Saru LV; Hodges JR; Alladi S
    Arch Clin Neuropsychol; 2020 Jul; 35(5):528-538. PubMed ID: 32188967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of the Taiwanese Version of ACE-III (T-ACE-III) to Detect Dementia in a Memory Clinic.
    Yu RC; Mukadam N; Kapur N; Stott J; Hu CJ; Hong CT; Yang CC; Chan L; Huang LK; Livingston G
    Arch Clin Neuropsychol; 2022 Feb; 37(3):692-703. PubMed ID: 34718367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the Addenbrooke's cognitive examination for detecting early Alzheimer's disease and mild vascular dementia in a German population.
    Alexopoulos P; Greim B; Nadler K; Martens U; Krecklow B; Domes G; Herpertz S; Kurz A
    Dement Geriatr Cogn Disord; 2006; 22(5-6):385-91. PubMed ID: 16960447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.